COCRYSTAL PHARMA, INC. Sales Revenue, Goods, Gross (Deprecated 2018-01-31)
COCRYSTAL PHARMA, INC. (COCP) reported Sales Revenue, Goods, Gross (Deprecated 2018-01-31) of $2.09 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsGross · last filed 2013-11-18
- COCRYSTAL PHARMA, INC. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $2.09M, a 55.92% decline year-over-year.
- COCRYSTAL PHARMA, INC. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $1.96M, a 60.18% decline year-over-year.
- COCRYSTAL PHARMA, INC. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $2.03M, a 42.20% decline year-over-year.
- COCRYSTAL PHARMA, INC. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $4.33M, a 18.06% increase year-over-year.
- COCRYSTAL PHARMA, INC. sales revenue, goods, gross (deprecated 2018-01-31) for fiscal 2012 was $17.19M, a 36.38% increase from fiscal 2011.
- COCRYSTAL PHARMA, INC. sales revenue, goods, gross (deprecated 2018-01-31) for fiscal 2011 was $12.61M, a 17.36% decline from fiscal 2010.
- COCRYSTAL PHARMA, INC. sales revenue, goods, gross (deprecated 2018-01-31) for fiscal 2010 was $15.25M.
| Period end | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2013-09-30 | $2.09M 10-Q · filed 2013-11-18 | $4.04M derived: sum of 2 quarters · filed 2013-11-18 | $5.76M 10-Q · filed 2013-11-18 | $10.40M derived: sum of 4 quarters · filed 2013-11-18 | ||
| 2013-06-30 | $1.96M 10-Q · filed 2013-08-15 | $3.98M 10-Q · filed 2013-08-15 | $8.31M derived: sum of 3 quarters · filed 2013-08-15 | $13.05M derived: sum of 4 quarters · filed 2013-11-18 | ||
| 2013-03-31 | $2.03M 10-Q · filed 2013-05-10 | $6.36M derived: sum of 2 quarters · filed 2013-05-10 | $11.09M derived: sum of 3 quarters · filed 2013-11-18 | $16.00M derived: sum of 4 quarters · filed 2013-11-18 | ||
| 2012-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $9.06M derived: sum of 2 quarters · filed 2013-11-18 | $13.98M derived: sum of 3 quarters · filed 2013-11-18 | $17.19M 10-K · filed 2013-04-01 | ||
| 2012-09-30 | $4.73M 10-Q · filed 2013-11-18 | $4.89M 10-Q · filed 2012-11-14 | $9.65M derived: sum of 2 quarters · filed 2013-11-18 | $12.86M 10-Q · filed 2013-11-18 | $13.32M 10-Q · filed 2012-11-14 | $16.82M derived: sum of 4 quarters · filed 2013-11-18 |
| 2012-06-30 | $4.91M 10-Q · filed 2013-08-15 | $8.42M 10-Q · filed 2013-08-15 | $12.09M derived: sum of 3 quarters · filed 2013-08-15 | $16.02M derived: sum of 4 quarters · filed 2013-08-15 | ||
| 2012-03-31 | $3.51M 10-Q · filed 2013-05-10 | $7.18M derived: sum of 2 quarters · filed 2013-05-10 | $11.11M derived: sum of 3 quarters · filed 2013-05-10 | $13.68M derived: sum of 4 quarters · filed 2013-05-10 | ||
| 2011-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $7.60M derived: sum of 2 quarters · filed 2013-04-01 | $10.17M derived: sum of 3 quarters · filed 2013-04-01 | $12.61M 10-K · filed 2013-04-01 | ||
| 2011-09-30 | $3.93M 10-Q · filed 2012-11-14 | $6.50M derived: sum of 2 quarters · filed 2012-11-14 | $8.94M 10-Q · filed 2012-11-14 | $13.42M derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2011-06-30 | $2.57M 10-Q/A · filed 2012-09-28 | $5.01M 10-Q/A · filed 2012-09-28 | $9.49M derived: sum of 3 quarters · filed 2012-10-02 | $14.00M derived: sum of 4 quarters · filed 2012-10-02 | ||
| 2011-03-31 | $2.80M 10-Q/A · filed 2012-10-02 | $6.92M derived: sum of 2 quarters · filed 2012-10-02 | $11.43M derived: sum of 3 quarters · filed 2012-10-02 | $14.58M derived: sum of 4 quarters · filed 2012-10-02 | ||
| 2010-12-31 | $4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $8.64M derived: sum of 2 quarters · filed 2012-04-16 | $11.78M derived: sum of 3 quarters · filed 2012-04-16 | $15.25M 10-K · filed 2012-04-16 | ||
| 2010-09-30 | $4.52M 10-Q · filed 2011-11-21 | $7.66M derived: sum of 2 quarters · filed 2011-11-21 | $11.13M 10-Q · filed 2011-11-21 | |||
| 2010-06-30 | $3.14M 10-Q/A · filed 2011-09-09 | $6.62M 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |